The EPIC-Norfolk Study

 

Proteomic signatures improve risk prediction for common and rare diseases.

Carrasco-Zanini J, Pietzner M, Davitte J, Surendran P, Croteau-Chonka DC, Robins C, Torralbo A, Tomlinson C, Grünschläger F, Fitzpatrick N, Ytsma C, Kanno T, Gade S, Freitag D, Ziebell F, Haas S, Denaxas S, Betts JC, Wareham NJ, Hemingway H, Scott RA, and Langenberg C

Nature medicine. Jul 2024

(DOI : 10.1038/s41591-024-03142-z)

---